GWTI GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES
Industrial Organic Chemicals · OTC · SEC CIK 1572386 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY94.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-420.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets510,697.3%
Debt / equity—
Current ratio0.00x
Interest coverage-3.21x
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio-104.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| R&D expense | $1.21M | $50,000 | — | $54,275 | $158,000 |
| SG&A expense | $2.49M | $844,305 | $960,692 | $888,599 | $962,901 |
| Operating income | -$3.69M | -$894,305 | -$960,692 | -$942,874 | -$1.12M |
| Interest expense | $613,135 | $619,263 | — | — | $588,273 |
| Pretax income | — | — | — | — | -$1.74M |
| Income tax | — | — | — | — | $0 |
| Net income | -$1.96M | -$1.51M | -$1.58M | -$1.51M | -$1.74M |
| EBITDA | — | — | — | — | -$1.12M |
| EPS (basic) | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Weighted avg. shares (diluted) | 444.86M | 413.13M | 397.74M | 371.60M | 342.40M |
| Balance sheet | |||||
| Cash & equivalents | $850 | $20,139 | $1,132 | $24,595 | $60,549 |
| Current assets | $46,753 | $20,251 | $1,132 | $27,542 | $60,605 |
| PP&E, net | — | — | — | — | $0 |
| Total assets | $46,753 | $20,251 | $1,132 | $27,542 | $60,605 |
| Current liabilities | $14.13M | $13.03M | $12.03M | $10.77M | $9.95M |
| Total liabilities | $14.13M | $13.03M | $12.03M | $10.77M | $9.95M |
| Shareholders' equity | -$14.08M | -$13.01M | -$12.03M | -$10.74M | -$9.89M |
| Shares outstanding | 456.36M | 430.84M | 403.84M | 382.61M | 355.06M |
| Cash flow statement | |||||
| Operating cash flow | -$710,289 | -$444,223 | -$302,663 | -$496,654 | -$791,906 |
| Financing cash flow | $691,000 | $463,230 | $279,200 | $460,700 | $850,827 |
| Depreciation & amortization | — | — | — | — | $0 |
| Stock-based compensation | — | — | — | $6,500 | $14,475 |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.